Kriti Nutrients Limited (KRITINUT) AI Stock Analysis

• Market Cap: ₹3.22B
• Dividend Yield: 0.43%
• Average Volume (3M): 2.44K
• Price to Earnings (P/E): 9.4
• Beta (1Y): 1.80
• Revenue Growth: 16.35%
• EPS Growth: -32.55%
• Country: IN
• Employees: 230
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 1.83
• Shares Outstanding: 50,103,520
• 10 Day Avg. Volume: 4,941
• 30 Day Avg. Volume: 2,442
• PEG Ratio: -0.76
• Price to Book (P/B): 2.41
• Price to Sales (P/S): 0.70
• P/FCF Ratio: 18.73
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 60 Neutral
• Price Target: ₹68.00 ▼(-13.49% Downside)
• Action: Reiterated Date: 10/23/25
• Date: Action: Reiterated 10/23/25

Kriti Nutrients Limited's overall stock score is primarily influenced by its strong financial performance, particularly its robust balance sheet. However, bearish technical indicators and modest valuation metrics suggest caution. The company needs to address profitability and cash flow challenges to improve its stock attractiveness.

Positive Factors

Robust balance sheet

Extremely low leverage and a high equity ratio provide durable financial resilience against commodity-price swings and seasonal working capital needs. Strong ROE indicates effective capital use, supporting long-term stability, access to funding, and capacity to invest in processing assets or expansion.

Consistent revenue growth

Sustained top-line growth indicates steady demand for its edible oils and soy products and supports higher plant utilization. Consistent revenues underpin scale advantages, enable fixed-cost absorption across cycles, and make medium-term planning for capacity or product diversification more viable.

Operational margin resilience

Healthy gross and EBITDA margins signal operational efficiency in crushing and refining processes, implying the company can sustain core profitability despite commodity volatility. Durable margin structure supports reinvestment capacity and buffers against short-term swings in input prices.

Negative Factors

Declining net profit margin

Compression in net margin suggests rising costs, weaker pricing power, or adverse product mix that reduce retained earnings. Over months this erodes free cash available for capex or debt reduction and can constrain returns to shareholders unless cost or pricing dynamics are improved.

Weak free cash flow trends

Deteriorating free cash flow and sub‑1.0 conversion ratios point to working capital or capex pressures that limit cash available for strategic investments, dividends, or buffer against low-margin periods. Persistent weakness reduces financial flexibility over the medium term.

Earnings growth contraction

Material negative EPS growth signals earnings volatility or one-off hits impacting profitability. Continued contraction undermines the durability of ROE and may reflect structural margin or demand issues, complicating reinvestment and weakening capacity to grow shareholder value.

Kriti Nutrients Limited Business Overview & Revenue Model

Company Description

Kriti Nutrients Limited engages in the manufacture and sale of soyabean seeds under the Kriti brand in India and internationally. It offers edible oils, such as refined sunflower oil, soya bean oil, filtered groundnut oil, and mustard oil; soya lecithin; protein-based nuggets/TVP, full fat soya flour, defatted flakes/ grits/ flour toasted, defatted flakes/ grits/ flour untoasted, super HyPro SBM, and soya hulls; and acid oil and fatty acids. The company serves food, pharmaceutical, aquaculture and poultry, and dairy industries. It also exports its products. The company was founded in 1992 and is based in Indore, India. Kriti Nutrients Limited is a subsidiary of Sakam Trading Private Limited.

How the Company Makes Money

Kriti Nutrients Limited makes money primarily by processing oilseeds (notably soybeans) and selling the resulting products across the edible oil and soy-products value chain. Key revenue streams generally include: (1) Sale of edible oils (such as refined or processed oils) sold to distributors, wholesalers, institutional buyers, and/or other downstream food companies; (2) Sale of soy derivatives/co-products generated during crushing and processing (e.g., soy meal/cake or other by-products) that are sold into animal feed and other industrial or food applications; and (3) Trading and/or distribution activity, if undertaken, where the company buys and sells oils or oilseeds to optimize plant utilization and market opportunities. Earnings are influenced by crushing spreads (the margin between oilseed input costs and realized prices of oil and by-products), capacity utilization, working-capital efficiency, commodity price volatility (soybean and edible oil prices), and demand conditions in edible oil and feed markets. Specific details on customer concentration, contract structure, export share, or named partnerships are null.

Kriti Nutrients Limited Financial Statement Overview

Summary

Kriti Nutrients Limited maintains a strong financial position with stable revenue growth and efficient operations. The balance sheet is robust with low leverage and high equity ratios. However, the decrease in net profit margin and free cash flow growth highlights areas for improvement in cost management and cash flow efficiency.

Income Statement

Kriti Nutrients Limited has shown a stable revenue growth with a 7.47% increase from 2024 to 2025. The gross profit margin for 2025 is 13.99%, which is consistent with industry standards. However, the net profit margin declined to 5.03% from 6.63% the previous year, indicating increased costs or reduced pricing power. EBITDA margin remains strong at 7.60%, suggesting efficient operations despite the reduced EBIT margin of 5.80%.

Balance Sheet

The company's balance sheet is robust, characterized by a low debt-to-equity ratio of 0.01, indicating minimal financial leverage. The equity ratio is high at 89.06%, reflecting strong equity backing. Return on equity is 17.46%, showing effective use of shareholder funds to generate profits. Overall, the balance sheet reflects financial stability with low risk exposure.

Cash Flow

Kriti Nutrients has demonstrated a decline in free cash flow growth, with a significant decrease from 2024 to 2025, posing a concern. The operating cash flow to net income ratio is 0.86, suggesting adequate conversion of net income into cash. However, free cash flow to net income is 0.74, indicating potential pressures on cash flow generation.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	8.15B	7.34B	6.83B	7.96B	7.51B	6.90B
Gross Profit	890.11M	1.03B	1.07B	780.37M	679.84M	378.97M
EBITDA	486.40M	557.89M	666.67M	356.28M	222.83M	242.58M
Net Income	315.50M	369.94M	452.87M	207.98M	123.05M	150.57M
Balance Sheet
Total Assets	2.56B	2.38B	2.09B	1.93B	1.68B	1.24B
Cash, Cash Equivalents and Short-Term Investments	521.26M	265.85M	210.43M	190.38M	37.16M	30.21M
Total Debt	59.08M	30.69M	121.45M	403.73M	375.58M	35.38M
Total Liabilities	271.89M	259.39M	325.25M	607.00M	554.76M	232.38M
Stockholders Equity	2.29B	2.12B	1.76B	1.32B	1.13B	1.01B
Cash Flow
Free Cash Flow	397.30M	273.10M	409.62M	133.43M	-193.72M	38.16M
Operating Cash Flow	427.15M	319.58M	498.13M	198.61M	-105.10M	90.22M
Investing Cash Flow	-321.63M	-288.64M	-291.87M	-31.35M	-199.81M	11.95M
Financing Cash Flow	13.72M	-106.49M	-304.01M	-14.05M	311.86M	-72.13M

Kriti Nutrients Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 78.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Negative. The current price of 78.6 is above the 20-day moving average (MA) of 69.21, above the 50-day MA of 71.71, and below the 200-day MA of 88.48, indicating a bearish trend. The MACD of -2.43 indicates Positive momentum. The RSI at 40.98 is Neutral, neither overbought nor oversold. The STOCH value of 37.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KRITINUT.

Kriti Nutrients Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
PASHUPATI	62 Neutral	₹15.72B	120.13	―	0.06%	―	―
KRITINUT	60 Neutral	₹3.22B	9.38	―	0.43%	16.35%	-32.55%
IFBAGRO	58 Neutral	₹7.01B	43.53	―	―	23.11%	1930.97%
SAKHTISUG	56 Neutral	₹1.80B	-1.68	―	―	1.70%	-71.32%
KOTHARIPRO	54 Neutral	₹3.77B	11.19	―	―	-3.96%	―
TRF	52 Neutral	₹2.52B	14.28	―	―	-29.77%	-60.54%

Kriti Nutrients Limited Corporate Events

Kriti Nutrients Confirms SEBI Dematerialisation Compliance for December Quarter

Kriti Nutrients Limited has confirmed that, for the quarter ended 31 December 2025, all securities submitted for dematerialisation have been duly processed in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Based on a certificate from its registrar and share transfer agent, the company reported that the dematerialised securities are listed on the recognised stock exchanges, and that the corresponding physical certificates have been verified, mutilated, cancelled and the depositories recorded as the registered owners within the stipulated 15-day timeframe, underscoring ongoing adherence to regulatory norms and safeguarding of shareholder records.